Giving wings to Ideas

The recent past has seen many landmark legal decisions which hinge on intellectual property rights: how they define and protect the science behind more effective medicines. But of what use is innovation if it is held back from the very people it is meant to serve? How do we strike a balance between public and private interest? Express Pharma‘s 18th anniversary issue therefore presents different perspectives of innovation

– Ranjit Shahani, President, OPPI and Vice Chairman and Managing Director, Novartis India
– Kiran Mazumdar-Shaw, CMD, Biocon
– Dr P Murali, President, ABLE and CEO, Evolva Biotech
– Leena Menghaney, India Campaign Manager Access Campaign Médecins Sans Frontières
– Prof Raghavendra Lal Saha, Chairman, IPR committee Ministry of MSME Government of India
– Reji K Joseph, Consultant RIS, a think tank with Government of India
– Anay Shukla, Member, Pharma and Life Science team, Nishith Desai Associates
– Dr Gopakumar G Nair, Founder, Gopakumar Nair Associates (GNAs) and CEO, Patent Gurukul
– Raghu Cidambi, Advisor, Indian Pharmaceutical Alliance
– Priyanka Gupta, Solution Consultant, IP & Science business of Thomson Reuters
– Adefemi Adenuga, GlobalData’s analyst covering healthcare industry dynamics
– Tapan Ray, Director General, OPPI
– Anjan Sen, Director, Deloitte Touche Tohmatsu India
– Milind Sathe, Deputy General Manager – Projects, Unichem Laboratories
– Kannan Vijayaraghavan, Chairman, Sathguru Management Consultants
– Nick Mitchell, Phenomenex India